Although further investigations are needed, our study lays the groundwork to consider SIRT3 as a new target to counteract the advantages for tumor proliferation deriving from an acidic microenvironment and, consequently, increase therapy sensitivity, therefore suggesting the possible use of SIRT3 modulators as a novel cancer therapeutic strategy. The gene discussed is SIRT3; the disease is neoplasm.